Neuro Device Group

Neuro Device Group

Neuro Device Group

We create the future of neuroscience. Innovative solutions for research & therapy of central nervous system.
Type
Platform
Founded
2016
Follow us
Featured on
Alexa global traffic share
Twitter followers
Team Size
30+
Employees
Location
Headquarters

Product overview

the problem

Aphasia is a common stroke-related disorder. Affects app. 5 million people/yr. Causes inability to understand and communicate while being intellectually intact. 25% of those affected are below 40 yr old. Cost of aphasia in EU: €13,5 billion/yr.

the solution

World’s first comprehensive rehabilitation system for aphasia therapy. It will make a great change in quality of therapy, enhancing and accelerating it results. I will also make it more accessible and affordable by significantly reducing its costs.

target group

App. 15 million people worldwide suffer a stroke each year. And around 30% of them suffers from aphasia. There are estimates that 1 in 250 lives with aphasia in the world, what is more common than Parkinson’s disease.

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Neuro Device Group makes some noise.